ATRYS HEALTH (Germany) Market Value
A2T Stock | EUR 2.93 0.07 2.33% |
Symbol | ATRYS |
ATRYS HEALTH 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ATRYS HEALTH's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ATRYS HEALTH.
12/17/2024 |
| 03/17/2025 |
If you would invest 0.00 in ATRYS HEALTH on December 17, 2024 and sell it all today you would earn a total of 0.00 from holding ATRYS HEALTH SA or generate 0.0% return on investment in ATRYS HEALTH over 90 days. ATRYS HEALTH is related to or competes with Novo Nordisk, CSL, CSL, Mercedes-Benz Group, Vertex Pharmaceuticals, Moderna, and WUXI BIOLOGICS. Atrys Health, S.A., a biomedical company, provides diagnostic services and medical treatments More
ATRYS HEALTH Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ATRYS HEALTH's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ATRYS HEALTH SA upside and downside potential and time the market with a certain degree of confidence.
Downside Deviation | 3.24 | |||
Information Ratio | 0.0516 | |||
Maximum Drawdown | 20.43 | |||
Value At Risk | (2.79) | |||
Potential Upside | 7.31 |
ATRYS HEALTH Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ATRYS HEALTH's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ATRYS HEALTH's standard deviation. In reality, there are many statistical measures that can use ATRYS HEALTH historical prices to predict the future ATRYS HEALTH's volatility.Risk Adjusted Performance | 0.0253 | |||
Jensen Alpha | 0.168 | |||
Total Risk Alpha | 0.4569 | |||
Sortino Ratio | 0.0509 | |||
Treynor Ratio | 0.0546 |
ATRYS HEALTH SA Backtested Returns
At this point, ATRYS HEALTH is relatively risky. ATRYS HEALTH SA secures Sharpe Ratio (or Efficiency) of 0.0145, which signifies that the company had a 0.0145 % return per unit of risk over the last 3 months. We have found thirty technical indicators for ATRYS HEALTH SA, which you can use to evaluate the volatility of the firm. Please confirm ATRYS HEALTH's risk adjusted performance of 0.0253, and Mean Deviation of 1.84 to double-check if the risk estimate we provide is consistent with the expected return of 0.0428%. ATRYS HEALTH has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.03, which signifies a somewhat significant risk relative to the market. ATRYS HEALTH returns are very sensitive to returns on the market. As the market goes up or down, ATRYS HEALTH is expected to follow. ATRYS HEALTH SA currently shows a risk of 2.95%. Please confirm ATRYS HEALTH SA jensen alpha, sortino ratio, maximum drawdown, as well as the relationship between the total risk alpha and treynor ratio , to decide if ATRYS HEALTH SA will be following its price patterns.
Auto-correlation | -0.23 |
Weak reverse predictability
ATRYS HEALTH SA has weak reverse predictability. Overlapping area represents the amount of predictability between ATRYS HEALTH time series from 17th of December 2024 to 31st of January 2025 and 31st of January 2025 to 17th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ATRYS HEALTH SA price movement. The serial correlation of -0.23 indicates that over 23.0% of current ATRYS HEALTH price fluctuation can be explain by its past prices.
Correlation Coefficient | -0.23 | |
Spearman Rank Test | -0.42 | |
Residual Average | 0.0 | |
Price Variance | 0.01 |
ATRYS HEALTH SA lagged returns against current returns
Autocorrelation, which is ATRYS HEALTH stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting ATRYS HEALTH's stock expected returns. We can calculate the autocorrelation of ATRYS HEALTH returns to help us make a trade decision. For example, suppose you find that ATRYS HEALTH has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
ATRYS HEALTH regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If ATRYS HEALTH stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if ATRYS HEALTH stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in ATRYS HEALTH stock over time.
Current vs Lagged Prices |
Timeline |
ATRYS HEALTH Lagged Returns
When evaluating ATRYS HEALTH's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of ATRYS HEALTH stock have on its future price. ATRYS HEALTH autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, ATRYS HEALTH autocorrelation shows the relationship between ATRYS HEALTH stock current value and its past values and can show if there is a momentum factor associated with investing in ATRYS HEALTH SA.
Regressed Prices |
Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in ATRYS Stock
ATRYS HEALTH financial ratios help investors to determine whether ATRYS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ATRYS with respect to the benefits of owning ATRYS HEALTH security.